Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. REZI
REZI logo

REZI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Resideo Technologies Inc (REZI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
32.790
1 Day change
-2.53%
52 Week Range
45.290
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Resideo Technologies Inc (REZI) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, insider buying activity, and positive analyst sentiment outweigh the lack of immediate trading signals and neutral technical indicators. The asset aligns well with a long-term strategy.

Technical Analysis

The technical indicators are neutral. The MACD histogram is -0.307 and negatively contracting, RSI is at 34.908 (neutral zone), and moving averages are converging. The stock is trading near a key support level (S1: 32.659) with resistance at R1: 35.425.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • Insider buying activity has increased significantly by 287.76% over the last month.

  • Analysts have raised the price target to $50 from $42, citing a better-than-expected Q4 report and FY26 outlook.

  • Strong financial performance in Q4 2025 with significant growth in revenue, net income, EPS, and gross margin.

Neutral/Negative Catalysts

  • No recent news or event-driven catalysts.

  • Neutral hedge fund sentiment with no significant trading trends.

  • No recent congress trading data available.

Financial Performance

In Q4 2025, revenue increased by 1.99% YoY to $1.895 billion. Net income surged by 958.33% YoY to $127 million, and EPS grew by 962.50% YoY to 0.85. Gross margin improved by 3.56% YoY to 27.92%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley raised the price target to $50 from $42 and maintained an Overweight rating, citing improved execution and a better-than-expected Q4 report.

Wall Street analysts forecast REZI stock price to rise
2 Analyst Rating
Wall Street analysts forecast REZI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 33.640
sliders
Low
42
Averages
45
High
48
Current: 33.640
sliders
Low
42
Averages
45
High
48
Morgan Stanley
NULL -> Overweight
maintain
$42 -> $50
AI Analysis
2026-02-25
Reason
Morgan Stanley
Price Target
$42 -> $50
AI Analysis
2026-02-25
maintain
NULL -> Overweight
Reason
Morgan Stanley raised the firm's price target on Resideo to $50 from $42 and keeps an Overweight rating on the shares. The firm, which updated estimates following a "better-than-feared" Q4 report and FY26 outlook, feels "incrementally better" about execution, but adds "there is more 'wood to chop' in 2026."
Oppenheimer
Oppenheimer
Outperform
maintain
$35 -> $48
2025-09-19
Reason
Oppenheimer
Oppenheimer
Price Target
$35 -> $48
2025-09-19
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on Resideo to $48 from $35 and keeps an Outperform rating on the shares. With the indemnification settlement/payment complete, the firm believes Resideo remains a relatively unknown story with the potential for value recognition via accelerated growth and multiple expansion. The \"RemainCo\" Products & Solutions business is poised to benefit from recent product innovation/introductions. The \"SpinCo\" ADI segment could benefit from steady growth, M&A, and an increased mix of higher-margin exclusive/proprietary products, Oppenheimer adds.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for REZI
Unlock Now

People Also Watch